August 23, 2017 12:02 PM ET

Biotechnology

Company Overview of Acceleron Pharma Inc.

Executive Profile

Francois Nader M.D., M.B.A.

Chairman of The Board, Acceleron Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 11 different industries.

See Board Relationships
60$227,724

Background

Dr. Francois Nader, M.D., MBA is the Chairman of Acceleron Pharma, Inc. He served as the President, Chief Executive Officer and Executive Director of NPS Pharmaceuticals, Inc. from 2008 to 2015. Prior to joining NPS in 2006, Dr. Nader was a Venture Partner of Care Capital, LLC and served as the Chief Medical Officer for its Clinical Development Capital Unit from July 2005 to June 2006. He served on the North America Leadership Team of Aventis and its predecessor companies ...

Corporate Headquarters

128 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-649-9200
Fax: 617-649-9988

Board Members Memberships

2014-Present
Chairman of The Board
2014-Present
Director
2016-Present
Independent Non-Executive Director

Education

MD 1981
Saint Joseph's University
MBA 2000
University of Tennessee System, The

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$18,909
Unexercisable Options$21,667
Total Number of Options$40,576

Total Compensation

Total Annual Cash Compensation$70,000
Total Calculated Compensation$227,724
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Acceleron Pharma Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.